Goss J A, Yersiz H, Shackleton C R, Seu P, Smith C V, Markowitz J S, Farmer D G, Ghobrial R M, Markmann J F, Arnaout W S, Imagawa D K, Colquhoun S D, Fraiman M H, McDiarmid S V, Busuttil R W
Department of Surgery, University of California at Los Angeles, USA.
Transplantation. 1997 Sep 27;64(6):871-7. doi: 10.1097/00007890-199709270-00014.
The shortage of cadaveric donor livers is the rate-limiting step in clinical liver transplantation. Split liver transplantation provides a means to expand the cadaveric donor pool. However, this concept has not reached its full potential because of inferior patient and graft survival and high complication rates when traditional ex vivo split techniques are used. Therefore we sought to evaluate the safety, applicability, and effectiveness of a new technique for split liver transplantation.
This study consists of 15 in situ split liver procurements, which resulted in 28 liver transplants. In situ splitting of selected livers from hemodynamically stable cadaveric donors was performed at the donor hospital without any additional work-up or equipment being needed. In situ liver splitting is accomplished in a manner identical to the living-donor procurement. This technique for liver splitting results in a left lateral segment graft (segments 2 and 3) and a right trisegmental graft (segments 1 and 4-8). This procedure required the use of the donor hospital operating room for an additional 1.5-2.5 hr and did not interfere with the procurement of 30 kidneys, 12 hearts, 7 lungs, and 9 pancreata from these same donors.
The 6-month and 1-year actuarial patient survival rates were 92% and 92%, respectively, while the 6-month and 1-year actuarial graft survival rates were 86% and 86%, respectively. The 6-month and 1-year actuarial patient survival rate of patients who received a left lateral segment graft was 100% and 100%, respectively, while those who received a right trisegmental graft had 6-month and 1-year rates of 86% and 86%, respectively. The actuarial death-censored graft survival rates at 6 months and 1 year were 80% and 80%, respectively, for the left lateral segment grafts, and 93% and 93%, respectively, for the right trisegmental grafts. Alograft and patient survival was independent of United Network for Organ Sharing status at the time of liver transplantation. No patient developed a biliary stricture, required re-exploration for intra-abdominal hemorrhage, or suffered from portal vein, hepatic vein, or hepatic artery thrombosis
In situ split liver transplantation can be accomplished without complications and provides results that are superior to those obtained previously with ex vivo methods. It abolishes ex vivo benching and prolonged ischemia times and provides two optimal grafts with hemostasis accomplished. This technique decreases pediatric waiting time and allows adult recipients to receive right-sided grafts safely. In situ splitting is the method of choice for expanding the cadaveric liver donor pool.
尸体供肝短缺是临床肝移植的限速步骤。劈离式肝移植为扩大尸体供肝库提供了一种方法。然而,由于采用传统体外劈离技术时患者和移植物存活率较低且并发症发生率较高,这一概念尚未充分发挥其潜力。因此,我们试图评估一种新的劈离式肝移植技术的安全性、适用性和有效性。
本研究包括15例原位劈离式肝获取,共进行了28例肝移植。在供体医院对血流动力学稳定的尸体供体的选定肝脏进行原位劈离,无需任何额外的检查或设备。原位肝劈离的方式与活体供肝获取相同。这种肝劈离技术产生一个左外侧叶移植物(第2和3段)和一个右三叶移植物(第1和4 - 8段)。该操作需要在供体医院手术室额外花费1.5 - 2.5小时,且不影响从这些相同供体获取30个肾脏、12颗心脏、7个肺和9个胰腺。
6个月和1年的实际患者生存率分别为92%和92%,而6个月和1年的实际移植物生存率分别为86%和86%。接受左外侧叶移植物的患者6个月和1年的实际生存率分别为100%和100%,而接受右三叶移植物的患者6个月和1年的生存率分别为86%和86%。左外侧叶移植物6个月和1年的实际死亡校正移植物生存率分别为80%和80%,右三叶移植物分别为93%和93%。移植物和患者的存活与肝移植时器官共享联合网络的状态无关。没有患者发生胆管狭窄,无需因腹腔内出血再次手术探查,也没有发生门静脉、肝静脉或肝动脉血栓形成。
原位劈离式肝移植可无并发症地完成,其结果优于先前的体外方法。它消除了体外操作和延长的缺血时间,并提供了两个止血完成的最佳移植物。该技术缩短了儿童等待时间,并使成人受者能够安全地接受右侧移植物。原位劈离是扩大尸体肝供体库的首选方法。